Balancing Act: Treatment Choices and Side Effects in Metastatic Breast Cancer
There are many treatment options for metastatic breast cancer, including clinical trials. How do you and your care team balance how well the treatment works with how its side effects impact your daily life?
This panel discussion, featuring a medical oncologist and people living with metastatic disease, explores how you and your doctor talk about options and weigh possible risks and benefits of treatment. We’ll also discuss how your priorities and approach may change when you need to move on to new treatments. Our panelists will share how they viewed their treatment options over time, including if, and how, they thought about whether to stop treatment.
As part of this program, you will have an opportunity to ask questions on this topic during a live Q&A.
About Our Speakers
Pallav Mehta, MD
Pallav Mehta, MD, is the director of integrative oncology and director of practice development at the MD Anderson Cancer Center at Cooper in Camden, New Jersey. He is a medical oncologist/hematologist with expertise and interest in breast cancer and integrative oncology and is board certified in oncology, hematology and integrative medicine. He is a member of Living Beyond Breast Cancer’s Board of Directors. Read more.
Sheila McGlown, a retired Air Force Senior Master Sergeant and mother of one, was diagnosed with stage IV HER2-positive, estrogen receptor-positive breast cancer in 2009, at age 43. She was diagnosed at stage IV “de novo,” from first diagnosis, with mets in her liver and ribs. Read more.
Marina Kaplan has been living with metastatic triple-negative breast cancer for 6 years. Diagnosed at stage II in 2011, she progressed to stage IV, metastatic, in 2013. She lives in Atlantic Beach, Florida with her husband and two dogs, and is the proud mother of wonderful twin daughters. Read more.